Cullinan Therapeutics
CGEM
#6219
Rank
A$1.07 B
Marketcap
$18.53
Share price
5.94%
Change (1 day)
33.35%
Change (1 year)

Earnings for Cullinan Therapeutics (CGEM)

Earnings in 2024 (TTM): -A$0.28 Billion

According to Cullinan Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$0.31 Billion a decrease over its 2022 earnings that were of -A$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cullinan Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.28 Billion-8.68%
2023 -A$0.31 Billion44.28%
2022 -A$0.22 Billion94.45%
2021 -A$0.11 Billion12.63%
2020 -A$96.38 Million